FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21714111000001108: Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Apr 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73166601000001117 Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73166701000001110 Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Is a Ursodeoxycholic acid 500mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has AMP Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has specific active ingredient Ursodeoxycholic acid true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd) 100 tablet 4 x 25 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start